More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$5.90B
EPS
-0.28
P/E ratio
--
Price to sales
2.46
Dividend yield
--
Beta
1.421679
Previous close
$76.89
Today's open
$76.24
Day's range
$74.77 - $76.59
52 week range
$50.82 - $85.84
show more
CEO
Howard G. Berger
Employees
9276
Headquarters
Los Angeles, CA
Exchange
NASDAQ Global Market
Shares outstanding
78774892
Issue type
Common Stock
Healthcare
Medical Diagnostics & Screening
Wall Street Analysts Believe RadNet (RDNT) Could Rally 25.13%: Here's is How to Trade
The consensus price target hints at a 25.1% upside potential for RadNet (RDNT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
Zacks Investment Research • 9 hours ago

Why RadNet (RDNT) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks Investment Research • Nov 13, 2026

RadNet's Imaging Growth Can Fund DeepHealth's Hospital Rollout
RadNet's advanced imaging mix is improving as faster scanners help its centers handle more complex exams. Their DeepHealth software has also secured larger external contracts, which shows it can sell well beyond RDNT's own centers. In that sense, ONRAD's hospital relationships should give RDNT yet another route to sell DeepHealth alongside radiology services.
Seeking Alpha • Nov 12, 2026

RadNet: 3 Key Takeaways for Long-Term Investors
RadNet agreed to acquire ONRAD to directly serve over 225 hospitals. Digital Health's total contract value reached $108 million year-to-date.
The Motley Fool • Nov 10, 2026

RadNet: A 'Buy' On Sizable Q3 Beat And Value-Generating M&A
I assign a "Buy" rating to RadNet, Inc. following a substantial 3Q2026 earnings beat and a value-enhancing ONRAD acquisition. RDNT's advanced imaging mix shift, operating leverage, and AI-driven cost controls are driving margin expansion and profit outperformance. The ONRAD acquisition enables inpatient market penetration and immediate geographic expansion and is expected to be margin-accretive given ONRAD's >30% EBITDA margins.
Seeking Alpha • Nov 10, 2026

RadNet Q3 Earnings Call Highlights
RadNet NASDAQ: RDNT reported record third-quarter revenue and adjusted EBITDA as demand for advanced imaging, acquisitions and growth in its Digital Health business helped drive results. The company also raised its full-year outlook for its imaging center segment.
MarketBeat • Nov 9, 2026

RadNet, Inc. (RDNT) Q3 2026 Earnings Call Transcript
RadNet, Inc. ( RDNT ) Q3 2026 Earnings Call November 9, 2026 10:30 AM EST Company Participants Mark Stolper - Executive VP & CFO Howard Berger - Chairman, President & CEO Cornelis Wesdorp - President & CEO of Digital Health Sham Sokka - Chief Operating and Technology Officer of Digital Health Conference Call Participants Brian Tanquilut - Jefferies LLC, Research Division Clarke Murphy - Truist Securities, Inc., Research Division Andrew Mok - Barclays Bank PLC, Research Division Matthew Gillmor - KeyBanc Capital Markets Inc., Research Division Yuan Zhi - B. Riley Securities, Inc., Research Division James Sidoti - Sidoti & Company, LLC Presentation Operator Good morning, and welcome to the RadNet, Inc. Third Quarter 2026 Financial Results Conference Call.
Seeking Alpha • Nov 9, 2026

RadNet (RDNT) Reports Q3 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for RadNet (RDNT) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Zacks Investment Research • Nov 9, 2026

RadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2026 Financial Guidance Ranges
LOS ANGELES, Nov. 08, 2026 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective outpatient diagnostic imaging services and a premier global developer of digital health solutions, today reported financial results for its third quarter of 2026.
GlobeNewsWire • Nov 8, 2026

RadNet (RDNT) Q3 Earnings Preview: What You Should Know Beyond the Headline Estimates
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for RadNet (RDNT), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended September 2026.
Zacks Investment Research • Nov 5, 2026

¹ Disclosures

Open an M1 investment account to buy and sell RadNet Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.